HYFM does not currently support a meaningful analyst price-target aggregate. Yahoo Finance lists no one-year target estimate, and MarketBeat shows a single "Sell" rating. A lone $6.50 target is clearly stale, reflecting a period in 2025 when shares traded near $3.70 before the collapse. A separate two-analyst poll reported by Investing.com points to a $0.90–$1.15 range (average about $1.03), but those figures cannot be attributed to named firms or dates and so are treated as context only. Because no verified consensus exists, this article uses a fallback objective of $1.00 — a round-number psychological level that sits within that thin public range and near the stock's 200-day moving average — rather than any analyst-derived figure. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how the stock compares to others in the industry.
Hydrofarm Holdings Group, Inc. manufactures and distributes hydroponics equipment and supplies for controlled environment agriculture (CEA), serving cannabis and specialty-crop growers across the U.S. and Canada. The stock last closed near $0.82 with a 52-week range of $0.50 to $3.20, leaving a market capitalization of roughly $10 million. Reaching $1.00 would require a rise of about 22% — a substantial move for a company still shrinking and losing money, even if modest compared with the name's extreme historical volatility.
The clearest positive catalyst is balance-sheet repair. The company eliminated roughly $109 million in senior secured term debt through a restructuring, funded in part by the approximately $16 million sale of its Aurora Peat Products assets and a private placement. That removes a near-term overhang and improves liquidity even as operations remain weak. Management has also delivered consecutive quarterly selling, general, and administrative (SG&A) cost savings and is pruning its product portfolio, which could eventually improve margins. A rebound in cannabis and specialty-crop demand, or further asset monetization, would bolster the case. From what I see, this debt reduction stands out as the most concrete near-term positive.
The obstacles are significant. Revenue is in sustained decline — trailing twelve-month sales around $106 million, with a recent quarter's net sales down sharply year over year — and the company continues to post large net losses, reflecting impairments and weak demand. Shareholders' equity is negative, and the firm has faced Nasdaq listing-compliance concerns. Any weakening in hydroponics and CEA demand, further tariff or sourcing pressure, or dilution from additional capital raises could keep the share price below $1.00. I'm watching this closely because the revenue trajectory remains the primary concern.
HYFM trades below both its 50-day moving average (near $0.88) and its 200-day moving average (near $1.04). The $0.50 area represents the 52-week low and a key support zone, while $1.00 is the first psychologically significant resistance, reinforced by the 200-day average just above it. A sustained move through $1.00 would mark the first step toward repairing the longer-term downtrend.
Analyst price targets typically reflect a roughly 12-month research horizon, but no credible, current target exists here to anchor a timeframe. Investors should watch upcoming quarterly results, revenue trends, cash-flow and liquidity updates, any further restructuring or asset-sale announcements, and Nasdaq compliance status. Changes in cannabis-sector demand and any new equity issuance are also directly relevant. One thing that stands out is how quickly compliance issues could influence sentiment.
In my own analysis process, Tickeron’s AI Daily Buy/Sell Signals provide a useful layer when reviewing volatile names like this. The tool applies artificial intelligence to monitor thousands of stocks and ETFs in real time, generating Buy, Sell, or Hold signals as market conditions, technical behavior, and AI-driven analysis shift. For a highly volatile name like HYFM, such signals can help traders spot changing trends and manage positions more efficiently than manual scanning. Traders can use these signals to discover opportunities, monitor existing holdings, and react to momentum changes as they develop.
The $1.00 objective is a technical and psychological reference point rather than a published analyst consensus, reflecting roughly 22% upside from a price near $0.82. A cleaner balance sheet and cost discipline provide a plausible foundation, but persistent revenue declines, ongoing losses, negative equity, and listing risk are formidable counterweights. The absence of any credible analyst price forecast means the $1.00 level should be treated as a threshold to watch, not a prediction. The next earnings release and any further restructuring news are the most important signals for whether HYFM can approach that mark.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for HYFM turned positive on November 05, 2026. Looking at past instances where HYFM's MACD turned positive, the stock continued to rise in 44 of 50 cases over the following month. The odds of a continued upward trend are 88%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HYFM's RSI Oscillator exited the oversold zone, 31 of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 69 cases where HYFM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
Following a +13.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where HYFM advanced for three days, in 168 of 214 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
HYFM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HYFM as a result. In 82 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HYFM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HYFM entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.044) is normal, around the industry mean (2.277). P/E Ratio (-0.013) is within average values for comparable stocks, (3.106). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.745). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (0.041) is also within normal values, averaging (1.169).
The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. HYFM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HYFM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry TrucksConstructionFarmMachinery